Amicus Therapeutics Inc
NASDAQ:FOLD

Watchlist Manager
Amicus Therapeutics Inc Logo
Amicus Therapeutics Inc
NASDAQ:FOLD
Watchlist
Price: 11.42 USD -1.38% Market Closed
Market Cap: 3.4B USD
Have any thoughts about
Amicus Therapeutics Inc?
Write Note

Amicus Therapeutics Inc
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Amicus Therapeutics Inc
Free Cash Flow Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Amicus Therapeutics Inc
NASDAQ:FOLD
Free Cash Flow
-$48.1m
CAGR 3-Years
38%
CAGR 5-Years
32%
CAGR 10-Years
-1%
Abbvie Inc
NYSE:ABBV
Free Cash Flow
$17.8B
CAGR 3-Years
-3%
CAGR 5-Years
7%
CAGR 10-Years
14%
Gilead Sciences Inc
NASDAQ:GILD
Free Cash Flow
$6.9B
CAGR 3-Years
-7%
CAGR 5-Years
-2%
CAGR 10-Years
0%
Amgen Inc
NASDAQ:AMGN
Free Cash Flow
$5.5B
CAGR 3-Years
-15%
CAGR 5-Years
-10%
CAGR 10-Years
-1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Free Cash Flow
-$1.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-15%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Free Cash Flow
$3.2B
CAGR 3-Years
23%
CAGR 5-Years
11%
CAGR 10-Years
20%

See Also

What is Amicus Therapeutics Inc's Free Cash Flow?
Free Cash Flow
-48.1m USD

Based on the financial report for Jun 30, 2024, Amicus Therapeutics Inc's Free Cash Flow amounts to -48.1m USD.

What is Amicus Therapeutics Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
-1%

Over the last year, the Free Cash Flow growth was 64%. The average annual Free Cash Flow growth rates for Amicus Therapeutics Inc have been 38% over the past three years , 32% over the past five years , and -1% over the past ten years .

Back to Top